Literature DB >> 6685496

The value of the reserpine test in psychopharmacology.

M Bourin, M Poncelet, R Chermat, P Simon.   

Abstract

Numerous tests have been proposed to search for a possible antidepressive action. Many of these tests are based on a reversal of different reserpine effects, an approach justified mainly by the use of most the classic or new antidepressants. Three effects of reserpine were examined in mice: hypothermia, ptosis and akinesia. All tests were performed with reserpine 2.5 mg/kg, and the drugs were injected 4 h after reserpine administration. In these three models, we studied the relatively specific effects of 21 drugs known for their influence on the metabolism or action of norepinephrine (noradrenaline), serotonin and dopamine. Our results suggest that hypothermia antagonism is only obtained with drugs stimulating beta-adrenergic receptors directly or indirectly, ptosis antagonism with those stimulating alpha-adrenergic or serotonergic receptors, and akinesia antagonism with those stimulating dopaminergic receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685496

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  18 in total

1.  Tactile Stimulation on Adulthood Modifies the HPA Axis, Neurotrophic Factors, and GFAP Signaling Reverting Depression-Like Behavior in Female Rats.

Authors:  Kr Roversi; Caren Tatiane de David Antoniazzi; L H Milanesi; H Z Rosa; M Kronbauer; D R Rossato; T Duarte; M M Duarte; Marilise E Burger
Journal:  Mol Neurobiol       Date:  2019-02-11       Impact factor: 5.590

2.  Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol.

Authors:  H Francès; B Diquet; P Goldschmidt; P Simon
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram.

Authors:  H Wachtel; P A Löschmann
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1).

Authors:  H Frances; C Bulach; P Simon; M Fillion; G Fillion
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.

Authors:  M El Yacoubi; C Ledent; M Parmentier; R Bertorelli; E Ongini; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

6.  Methodological Considerations for Optimizing and Validating Behavioral Assays.

Authors:  Stacey J Sukoff Rizzo; Jill L Silverman
Journal:  Curr Protoc Mouse Biol       Date:  2016-12-01

7.  Antidepressant-Like Effect of Isorhynchophylline in Mice.

Authors:  Yan-Fang Xian; Ding Fan; Siu-Po Ip; Qing-Qiu Mao; Zhi-Xiu Lin
Journal:  Neurochem Res       Date:  2016-11-30       Impact factor: 3.996

8.  Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses.

Authors:  Ying Xu; Lu Zhang; Tuo Shao; Lina Ruan; Lin Wang; Jiao Sun; Jianxin Li; Xinbo Zhu; James M O'Donnell; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-04-14       Impact factor: 3.584

9.  Camellia euphlebia exerts its antidepressant-like effect via modulation of the hypothalamic-pituitary-adrenal axis and brain monoaminergic systems.

Authors:  Dongye He; Xuan Sai; Ning Wang; Xiaoyu Li; Lili Wang; Yongping Xu
Journal:  Metab Brain Dis       Date:  2017-12-16       Impact factor: 3.584

10.  Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system.

Authors:  Wu Huang; Zhuoyou Chen; Qiandong Wang; Mengmeng Lin; Shujuan Wu; Qizhi Yan; Fan Wu; Xuefeng Yu; Xupei Xie; Gaowen Li; Ying Xu; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-08-14       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.